Page last updated: 2024-09-04

rs 42358-197 and rs 25259-197

rs 42358-197 has been researched along with rs 25259-197 in 1 studies

Compound Research Comparison

Studies
(rs 42358-197)
Trials
(rs 42358-197)
Recent Studies (post-2010)
(rs 42358-197)
Studies
(rs 25259-197)
Trials
(rs 25259-197)
Recent Studies (post-2010) (rs 25259-197)
6001209

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, J; Bonhaus, DW; Clark, RD; Eglen, RM; Kowalczyk, BA; Lee, CH; Michel, AD; Miller, AB; Repke, DB; Weinhardt, KK1

Other Studies

1 other study(ies) available for rs 42358-197 and rs 25259-197

ArticleYear
2-(Quinuclidin-3-yl)pyrido[4,3-b]indol-1-ones and isoquinolin-1-ones. Potent conformationally restricted 5-HT3 receptor antagonists.
    Journal of medicinal chemistry, 1993, Sep-03, Volume: 36, Issue:18

    Topics: Animals; Cisplatin; Computer Simulation; Dogs; Ferrets; Isoquinolines; Male; Models, Molecular; Molecular Structure; Palonosetron; Pyridones; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists; Stereoisomerism; Structure-Activity Relationship; Vomiting

1993